128 related articles for article (PubMed ID: 12771950)
1. Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas.
Senchenko V; Liu J; Braga E; Mazurenko N; Loginov W; Seryogin Y; Bazov I; Protopopov A; Kisseljov FL; Kashuba V; Lerman MI; Klein G; Zabarovsky ER
Oncogene; 2003 May; 22(19):2984-92. PubMed ID: 12771950
[TBL] [Abstract][Full Text] [Related]
2. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.
Senchenko VN; Liu J; Loginov W; Bazov I; Angeloni D; Seryogin Y; Ermilova V; Kazubskaya T; Garkavtseva R; Zabarovska VI; Kashuba VI; Kisselev LL; Minna JD; Lerman MI; Klein G; Braga EA; Zabarovsky ER
Oncogene; 2004 Jul; 23(34):5719-28. PubMed ID: 15208675
[TBL] [Abstract][Full Text] [Related]
3. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
4. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
[TBL] [Abstract][Full Text] [Related]
5. Critical tumor-suppressor gene regions on chromosome 3P in major human epithelial malignancies: allelotyping and quantitative real-time PCR.
Braga E; Senchenko V; Bazov I; Loginov W; Liu J; Ermilova V; Kazubskaya T; Garkavtseva R; Mazurenko N; Kisseljov F; Lerman MI; Klein G; Kisselev L; Zabarovsky ER
Int J Cancer; 2002 Aug; 100(5):534-41. PubMed ID: 12124802
[TBL] [Abstract][Full Text] [Related]
6. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23.
Zhang Z; Gerhard DS; Nguyen L; Li J; Traugott A; Huettner PC; Rader JS
Genes Chromosomes Cancer; 2005 May; 43(1):95-103. PubMed ID: 15672406
[TBL] [Abstract][Full Text] [Related]
7. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene.
Sekido Y; Ahmadian M; Wistuba II; Latif F; Bader S; Wei MH; Duh FM; Gazdar AF; Lerman MI; Minna JD
Oncogene; 1998 Jun; 16(24):3151-7. PubMed ID: 9671394
[TBL] [Abstract][Full Text] [Related]
8. High resolution analysis of chromosome 3p alterations in cervical carcinoma.
Larson AA; Kern S; Curtiss S; Gordon R; Cavenee WK; Hampton GM
Cancer Res; 1997 Sep; 57(18):4082-90. PubMed ID: 9307297
[TBL] [Abstract][Full Text] [Related]
9. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.
Riquelme E; Tang M; Baez S; Diaz A; Pruyas M; Wistuba II; Corvalan A
Cancer Lett; 2007 May; 250(1):100-6. PubMed ID: 17084965
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease.
Angeloni D
Brief Funct Genomic Proteomic; 2007 Mar; 6(1):19-39. PubMed ID: 17525073
[TBL] [Abstract][Full Text] [Related]
11. A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3.
Oh JJ; West AR; Fishbein MC; Slamon DJ
Cancer Res; 2002 Jun; 62(11):3207-13. PubMed ID: 12036935
[TBL] [Abstract][Full Text] [Related]
12. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer.
Pulido HA; Fakruddin MJ; Chatterjee A; Esplin ED; Beleño N; Martinez G; Posso H; Evans GA; Murty VV
Cancer Res; 2000 Dec; 60(23):6677-82. PubMed ID: 11118052
[TBL] [Abstract][Full Text] [Related]
13. Analysis of molecular alterations in chromosome 8 associated with the development of uterine cervical carcinoma of Indian patients.
Bhattacharya N; Singh RK; Mondal S; Roy A; Mondal R; Roychowdhury S; Panda CK
Gynecol Oncol; 2004 Nov; 95(2):352-62. PubMed ID: 15491757
[TBL] [Abstract][Full Text] [Related]
14. Deletion mapping of chromosome 3p in human uterine cervical cancer.
Kohno T; Takayama H; Hamaguchi M; Takano H; Yamaguchi N; Tsuda H; Hirohashi S; Vissing H; Shimizu M; Oshimura M
Oncogene; 1993 Jul; 8(7):1825-32. PubMed ID: 8099726
[TBL] [Abstract][Full Text] [Related]
15. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
[TBL] [Abstract][Full Text] [Related]
16. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
[TBL] [Abstract][Full Text] [Related]
17. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms.
Jones MH; Nakamura Y
Oncogene; 1992 Aug; 7(8):1631-4. PubMed ID: 1630822
[TBL] [Abstract][Full Text] [Related]
18. The microcell hybrid-based "elimination test" identifies a 1-Mb putative tumor-suppressor region at 3p22.2-p22.1 centromeric to the homozygous deletion region detected in lung cancer.
Kholodnyuk ID; Kost-Alimova M; Yang Y; Kiss H; Fedorova L; Klein G; Imreh S
Genes Chromosomes Cancer; 2002 Jul; 34(3):341-4. PubMed ID: 12007195
[TBL] [Abstract][Full Text] [Related]
19. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
Sato M; Takahashi K; Nagayama K; Arai Y; Ito N; Okada M; Minna JD; Yokota J; Kohno T
Genes Chromosomes Cancer; 2005 Dec; 44(4):405-14. PubMed ID: 16114034
[TBL] [Abstract][Full Text] [Related]
20. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
